Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure.
Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C. Mulder P, et al. Among authors: barbier s. Circulation. 2004 Apr 6;109(13):1674-9. doi: 10.1161/01.CIR.0000118464.48959.1C. Epub 2004 Feb 23. Circulation. 2004. PMID: 14981003
Immunosuppressant regimen based on sirolimus decreases aortic stiffness in renal transplant recipients in comparison to cyclosporine.
Joannidès R, Monteil C, de Ligny BH, Westeel PF, Iacob M, Thervet E, Barbier S, Bellien J, Lebranchu Y, Seguin SG, Thuillez C, Godin M, Etienne I. Joannidès R, et al. Among authors: barbier s. Am J Transplant. 2011 Nov;11(11):2414-22. doi: 10.1111/j.1600-6143.2011.03697.x. Epub 2011 Sep 19. Am J Transplant. 2011. PMID: 21929645 Free article. Clinical Trial.
Sirolimus versus cyclosporine in kidney recipients receiving thymoglobulin, mycophenolate mofetil and a 6-month course of steroids.
Büchler M, Caillard S, Barbier S, Thervet E, Toupance O, Mazouz H, Hurault de Ligny B, Le Meur Y, Thierry A, Villemain F, Heng AE, Moulin B, Morin MP, Noël C, Lebranchu Y; SPIESSER Group. Büchler M, et al. Among authors: barbier s. Am J Transplant. 2007 Nov;7(11):2522-31. doi: 10.1111/j.1600-6143.2007.01976.x. Epub 2007 Sep 14. Am J Transplant. 2007. PMID: 17868057 Free article. Clinical Trial.
High dose epoetin beta in the first weeks following renal transplantation and delayed graft function: Results of the Neo-PDGF Study.
Martinez F, Kamar N, Pallet N, Lang P, Durrbach A, Lebranchu Y, Adem A, Barbier S, Cassuto-Viguier E, Glowaki F, Le Meur Y, Rostaing L, Legendre C, Hermine O, Choukroun G; NeoPDGF Study Investigators. Martinez F, et al. Among authors: barbier s. Am J Transplant. 2010 Jul;10(7):1695-700. doi: 10.1111/j.1600-6143.2010.03142.x. Am J Transplant. 2010. PMID: 20642691 Free article. Clinical Trial.
[Inflammation markers in daily practice].
Le Roy F, Barbier S, Passos EM, Godin M. Le Roy F, et al. Among authors: barbier s. Nephrologie. 2003;24(7):347-50. Nephrologie. 2003. PMID: 14650745 Review. French.
Optimization of initial tacrolimus dose using pharmacogenetic testing.
Thervet E, Loriot MA, Barbier S, Buchler M, Ficheux M, Choukroun G, Toupance O, Touchard G, Alberti C, Le Pogamp P, Moulin B, Le Meur Y, Heng AE, Subra JF, Beaune P, Legendre C. Thervet E, et al. Among authors: barbier s. Clin Pharmacol Ther. 2010 Jun;87(6):721-6. doi: 10.1038/clpt.2010.17. Epub 2010 Apr 14. Clin Pharmacol Ther. 2010. PMID: 20393454 Clinical Trial.
Pharmacokinetics of naftidrofuryl in patients with renal impairment.
Legallicier B, Barbier S, Bolloni L, Fillastre JP, Godin M, Kuhn T, Porte F, Chretien P, Dupain T, Bromet-Petitd M. Legallicier B, et al. Among authors: barbier s. Arzneimittelforschung. 2005;55(7):370-5. doi: 10.1055/s-0031-1296874. Arzneimittelforschung. 2005. PMID: 16080275
66 results